Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 23, 2022 - Issue 2
Submit an article Journal homepage
1,183
Views
0
CrossRef citations to date
0
Altmetric
Editorial

What are the considerations in the pharmacological management of opioid addiction in adolescents?

James Bell1 School of Social Policy, University of New South Wales, Kings Cross, Australia;2 Addictions Department, King’s College London, London, UKCorrespondence[email protected]
Pages 155-157 | Published online: 08 Nov 2021

References

  • King KM, Chassin L. A prospective study of the effects of age of initiation of alcohol and drug use on young adult substance dependence. J Stud Alcohol Drugs. 2007;68:256–265.
  • Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374:363–371.
  • Hodgins S, Larm P, Molero-Samuleson Y, et al. Multiple adverse outcomes over 30 years following adolescent substance misuse treatment. Acta Psychiatr Scand. 2009;119:484–493.
  • Ishino FAM, McNab PR, Gilreath T, et al. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017–2018 United States national survey. BMC Public Health. 2020;20:1740.
  • Bell J, Strang J. Medication treatment of opioid use disorder. Biol Psychiatry. 2020;87(1):82–88.
  • Feillin D. Treatment of adolescent opioid dependence - no quick fix. JAMA. 2008;300(17):2057–2059.
  • Mitchell SG, Monico LB, Gryczynski J, et al. Extended-release naltrexone for youth with opioid use disorder. J Subst Abuse Treat. 2021;130:108407.
  • Hadland SE, Bagley SM, Rodean J, et al. Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder. JAMA Pediatr. 2018;172(11):1029–1037.
  • Hopfer CJ, Khuri E, Crowley TJ, et al. Adolescent heroin use: a review of the descriptive and treatment literature. J Subst Abuse Treat. 2002;23(3):231–237.
  • Feder KA, Krawczyk N, Saloner B. Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder. J Adolesc Health. 2017;60(6):747–750.
  • Fishman M, Wenzel K, Scodes J, et al. Young adults have worse outcomes than older adults: secondary analysis of a medication trial for opioid use disorder. eJ Adolesc Health. 2020;67(2020):778e785.
  • Bell J, Mutch C. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence; a file review. Drug Alcohol Rev. 2006;25:167–171.
  • Robins L. Vietnam veterans’ rapid recovery from heroin addiction: a fluke, or normal expectation? Addiction. 1993;88:1041–1054.
  • Samet JH, Botticelli M, Bharel M. Methadone in primary care — one small step for congress, one giant leap for addiction treatment. NEJM. 2018;379(1):7–8.
  • Moos RH. Addictive disorders in context: principles and puzzles of effective treatment and recovery. Psychol Addict Behav. 2003;17(1):3–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.